论文部分内容阅读
脑出血在治疗过程中易合并高钠血症,而高钠血症是脑出血患者评估预后的独立危险因素,传统治疗方法如限制钠的摄入、输注低渗液体等往往效果不理想,且过快降低血钠可加重脑细胞水肿或发生中枢脱髓鞘病变。随着连续性肾脏替代疗法(CRRT)在急性肾功能衰竭及严重电解质紊乱中的广泛应用,使脑出血合并高钠血症的治疗有了新的选择。本研究旨在探讨CRRT对脑出血合并高钠血症的治疗价值,同时探讨CRRT的技术问题。
Intracerebral hemorrhage tends to be associated with hypernatremia during the course of treatment, while hypernatremia is an independent risk factor for prognosis in patients with intracerebral hemorrhage. Traditional treatment methods, such as restricting sodium intake and infusion of hypotonic fluid, often do not work well, And too fast to reduce serum sodium can increase brain cell edema or central demyelinating lesions. With the widespread use of continuous renal replacement therapy (CRRT) in acute renal failure and severe electrolyte disturbances, new options exist for the treatment of cerebral hemorrhage with hypernatremia. This study aimed to investigate the therapeutic value of CRRT on cerebral hemorrhage complicated with hypernatremia and to explore the technical problems of CRRT.